InRetail Peru Corp. Stocks

$ 26.83Last Updated 24.04.2026

Issuer Rating

4/7
Performance

Favourable

Risk

High

Recommendation

Hold

Market Cap

$ 2.85B

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
$ 26.83
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

InRetail Perú Corp., together with its subsidiaries, operates as a multi-format retailer primarily in Peru. The company operates through five segments: Food Retail, Pharmacies, Distribution, Shopping Center, and Digital. The Food Retail segment operates supermarkets, hypermarkets, discount stores, and cash and carry stores. The Pharmacies segment supplies of drugs, medicines, and cosmetic related products through the chain of pharmacies named Inkafarma and Mifarma. The Distribution segment distributes drugs, medicines, and consumer products. The Shopping Center segment leases commercial stores in shopping centers. The Digital segment manages, operates, and provides support in digital commerce services. The company is also involved in the real estate development business. The company was incorporated in 2011 and is based in Lima, Peru. InRetail Perú Corp. is a subsidiary of Intercorp Retail Inc.

Company Valuation

Undervalued
6/7

Based on key historical and expected multiples, the stock is undervalued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA, und

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks